Trial II

  • CMF + prednisone combined with or without oophorectomy for pre/perimenopausal patients with breast cancer and 4 or more positive nodes.

  • Study Chair
    Prof. Aron Goldhirsch - Milano, Italy

    Statistician
    Karen Price

    Director of the Data Management Center
    Holly Shaw

    IBCSG Data Management Center/FSTRF
    4033 Maple Road
    Amherst, New York 14226 USA
    Phone: +1 716 834 0900
    Fax: +1 716 833 3990
    Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

    Date of Activation
    July 1, 1978

    Date of Closure
    September 1, 1981

    Final Accrual
    1713 patients (1601 evaluable patients)

    Date of Discontinued Follow-up
    January 31, 2008

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: contact@etop.ibcsg.org

Member Login